Search clinical trials for: Pertussis immunisation

Total 901 results

St George's, University of London
European Society for Paediatric Infectious Diseases

Unknown

Maternal Antibody in Milk After Vaccination (MAMA)

Pertussis | Pregnancy | Vaccination | Breastmilk

United Kingdom
Duke University
Centers for Disease Control and Prevention; Children's Hospital Medical Center...

Completed

Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women (Tdap/IIV)

Pregnancy

United States
GlaxoSmithKline

Completed

Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults

Tetanus | Diphtheria | Acellular Pertussis

United States
Medical University of Vienna
Valneva Austria GmbH

Unknown

Immune Responses After a Booster Immunisation With IXIARO® in Elderly Compared to Young Individuals.

Japanese Encephalitis Vaccine

Austria
University of Toronto

Unknown

Feasibility of Implementation of CARD for School-Based Immunizations

Immunisation Anxiety Related Reaction

Canada
Imperial College London
Public Health England

Completed

Safety of Nasal Influenza Immunisation in Children With Asthma (SNIFFLE-4)

Asthma
Vabiotech
Vietstar Biomedical Research

Completed

The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks

Hepatitis B | Pertussis | Tetanus | Diphtheria | Haemophilus Influenzae Type B

Vietnam
MCM Vaccines B.V.
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Virus Diseases | Bacterial Infections
Crucell Holland BV
Retroscreen Virology Ltd.

Completed

Evaluation of the Protective Efficacy and Safety of CR8020 in an Influenza Challenge

Influenza

United Kingdom
Theresa Whiteside, PhD
Immune Cell Therapy Inc.

Terminated

Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer (NSCLC)

United States
University of Wisconsin, Madison
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)

Pulmonary Disease | Heart Failure With Preserved Ejection Fraction | Left Ventricular Hypertrophy/Hypertension

United States
MCM Vaccines B.V.
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)

Virus Diseases | Bacterial Infections
Prof. Elizabeth Miller

Completed

Evaluating Vaccine Responses in Healthy Infants Receiving Their Routine Primary Immunisation According to the Accelerated United Kingdom Schedule at 2, 3 and 4 Months (P13UK)

Streptococcus Pneumoniae

United Kingdom
Alopexx Vaccine, LLC

Completed

A Study of AV0328 Administered to Healthy Adult Volunteers

PNAG-expressing Pathogenic Microbes Vaccine

United States
GlaxoSmithKline

Completed

Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia

Poliomyelitis

Russian Federation
National Institute of Allergy and Infectious Diseases...

Completed

Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant

Influenza

United States
Michael A. Thompson, MD, PhD
Vince Lombardi Cancer Clinic

Completed

Study of the Immune Response After Vaccination in Multiple Myeloma Patients

Multiple Myeloma | Myeloma, Multiple | Myeloma-Multiple

United States
Interactive Research and Development
Harvard Medical School (HMS and HSDM)

Completed

Immunization Reminder Bracelets Study

Immunization; Infection

Pakistan
GlaxoSmithKline

Terminated

Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia

Diphtheria-Tetanus-Acellular Pertussis

Colombia
Duke University
Centers for Disease Control and Prevention; Kaiser Permanente

Completed

Fever After Simultaneous Versus Sequential Vaccination in Young Children

Fever | Febrile Seizure | Fever After Vaccination

United States
Ohio State University

Completed

Use of an Electronic Medical Record in the Primary Care Setting to Improve Herpes Zoster Vaccination Rates

Herpes Zoster Disease

United States
Centre Hospitalier le Mans

Unknown

Evaluation of a Tdap-IPV (Tetanus, Diphteria, Pertussis and Inactivated Polio) Vaccination Remedial Strategy on Vaccination Coverage in Patients 65 Years of Age or Older (HOSPIVAC)

Vaccination

France
Cancer Institute and Hospital, Chinese Academy...
Guangxi Center for Disease Control and Prevention

Unknown

Trail To Evaluate the Immune Effects of Primary and Booster Immunizations With Poliovirus Vaccine

Poliomyelitis

China
University Hospital, Limoges

Completed

Research Network for Neonatal Diseases Induced by Tissular Fetomaternal Alloimmunization

Hemochromatosis | Glomerulonephritis, Membranous | Neonatal Diseases and Abnormalities

France
Aga Khan University
World Health Organization

Unknown

Comparison of Immunity Following IPV Versus fIPV: a Community Based Randomized Controlled Trial in Pakistan (CODI)

Poliomyelitis | Immunization; Infection | Poliovirus Vaccine, Inactivated

Pakistan
Pfizer

Completed

Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants

Healthy Subjects

Japan
Dr. med. Micha Loebermann

Completed

Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

Germany
Merck Sharp & Dohme LLC
MCM Vaccines B.V.

Completed

Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)

Virus Diseases | Bacterial Infections
Merck Sharp & Dohme LLC
MCM Vaccines B.V.

Completed

A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

Virus Diseases | Bacterial Infections
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060)

Rotavirus Disease
Statens Serum Institut
Quintiles, Inc.; Bill and Melinda Gates Foundation; Larix A/S

Completed

3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infants

Poliomyelitis

Dominican Republic
GlaxoSmithKline

Completed

Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants

Tetanus | Diphtheria | Acellular Pertussis

Korea, Republic of
University of Oxford

Completed

A Study of the Interaction Between BCG And MenC Immunisation: BAM (BAM)

Immune Response | BCG Infection | Reaction - Vaccine

United Kingdom
GlaxoSmithKline

Withdrawn

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers

Respiratory Syncytial Virus Infections

Finland, United States, Spain
Lifespan Healthcare Resource Limited

Unknown

Immunization Schedule Alert Platform (ISAP)

Immunization

Nigeria
Novartis Vaccines

Completed

Immunogenicity and Safety of MenACWY in Infants (6 & 12 Months)

Meningococcal Meningitis

Canada
Luminex Molecular Diagnostics

Completed

A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients

Bordetella Infections | Bordetella Pertussis Infection | Bordetella Parapertussis Infection

United States, Canada
Centre for Infectious Disease Research in Zambia
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Causes of Rotavirus Vaccine Failure in Zambian Children

Diarrhoea

Zambia
GlaxoSmithKline

Completed

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

Finland, Dominican Republic
GlaxoSmithKline

Completed

Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months

Hepatitis A

United States
GlaxoSmithKline

Completed

Evaluation of Boostrix™10 Years After Previous Booster Vaccination

Tetanus | Diphtheria | Acellular Pertussis

Belgium
GlaxoSmithKline

Completed

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Neisseria Meningitidis | Haemophilus Influenzae Type b

Germany, France, Canada
GlaxoSmithKline

Completed

Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis

United Kingdom
GlaxoSmithKline

Completed

US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease

Tetanus | Diphtheria | Acellular Pertussis

United States
Human Genome Sciences Inc., a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

United States
GlaxoSmithKline

Completed

Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

Hepatitis B | Tetanus | Diphtheria | Haemophilus Influenzae Type b | Whole Cell Pertussis

Thailand
GlaxoSmithKline

Completed

Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

Hepatitis B | Tetanus | Diphtheria | Haemophilus Influenzae Type b | Whole Cell Pertussis

Philippines
University Hospital, Limoges

Completed

Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies

Preeclampsia | Recurrent Pregnancy Losses | Intervillositis

France
GlaxoSmithKline

Completed

Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents

Tetanus | Diphtheria | Acellular Pertussis

Mexico, Chile
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years

Tetanus | Diphtheria | Acellular Pertussis

United States

Search clinical trials for: Pertussis immunisation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations